Sigma Spectrum Infusion Pump Recall: Risk of Drug Overdose
Federal regulators have announced another infusion pump recall, this time involving the Sigma Spectrum infusion pump, which may fail and potentially deliver a fatal drug overdose without setting off an alarm to alert doctors.
Earlier this year, the FDA announced a new initiative to address safety problems with infusion pumps, which have been linked to more than 56,000 adverse event reports over the past five years, including at least 500 deaths. According to FDA data, there were 87 infusion pump recalls between 2005 and 2009 to address identified safety concerns.
The Sigma Spectrum pump recall was announced by the FDA on November 12, after the manufacturer, Sigma International, found that the units can fail suddenly. If the units fail, they could cause too little or too much medication to flow into the patient without healthcare professionals knowing about it.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The FDA has classified the infusion pump recall as a Class I medical device recall, meaning that the FDA believes that the device’s defect is likely to cause severe injury or death. However, there were no reports of injuries or deaths announced at the time of the recall.
The recall affects the SIGMA Spectrum Infusion Pump Model 35700. The recalled units have serial numbers ranging from 706497 to 724065. The units were manufactured from October 2006 through March 2008.
The company has informed customers by letter about the recall. They are being asked to return the pumps to the company, which will repair or replace them.
ByronSeptember 22, 2014 at 3:22 am
As a patient with an implanted time bomb, I will request my physician prescribe for me a Narcan self-administered "Narcan pen" to keep with me. Some urban police departments are encountering so many accidental heroin deaths that they provide kits to the high risk populations. The lease Medtronic can do is provide their clients with a fighting chance.
"*" indicates required fields
More Top Stories
With thousands of Bard hernia mesh lawsuits pending in the federal court system, a fourth bellwether trial will be held in the spring, involving allegations that defects with Bard 3DMax caused painful and permanent injuries.
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to warn doctors to conduct hearing tests, which could have helped a woman avoid permanent hearing damage.
A South Dakota man has filed one of the first gastroparesis lawsuits against Ozempic manufacturers, alleging that users have not been adequately warned about the risk of severe vomiting and long-term stomach side effects.